Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 14 November 1997:
Vol. 278. no. 5341, p. 1227
DOI: 10.1126/science.278.5341.1227
Prev | Table of Contents | Next

Research News

AIDS RESEARCH:
HIV Survives Drug Onslaught By Hiding Out in T Cells

Michael Balter

Potent new cocktails of anti-HIV drugs have been leading a counterattack against HIV, pounding the virus down to undetectable levels in the blood of many HIV-positive patients. But in this issue (pp. 1291 and 1295), two research teams report that while many patients taking these cocktails, known as combination therapy, for as long as 30 months show no signs of developing drug-resistant strains of HIV, they do still harbor latent virus in a small number of their T cells--immune cells that are HIV's primary target. And, in the test tube at least, these viruses can be induced to wake up and begin reproducing, simply by stimulating the T cells to become immunologically active--a condition known to be required for HIV to replicate.

Read the Full Text

ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)